Shishir Maithel

32PUBLICATIONS
97CO-AUTHORS
Cancer diagnosisPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jan 27, 2026
"Horses out of the barn": pancreatic ductal adenocarcinoma frequently extends beyond the grossly visible tumour, requiring microscopic rectification for accurate T-staging.

Burcu Saka, Bahar Memis, Serdar Balci

|Jan 11, 2026
Insulin-Dependence and Survival in Pancreatic Neuroendocrine Tumors: Results From the US-NTSG Group.

Muhammad Bilal Mirza, Jordan J Baechle, Paula Marincola Smith

|Dec 19, 2025
High-Dimensional Protein Analysis Uncovers Distinct Immunologic and Stromal Features in Primary and Metastatic Pancreatic Ductal Adenocarcinoma.

Emily Greene, Natalie K Horvat, Deon Bryant Doxie

|Nov 02, 2025
Intersection of Black race and carbohydrate antigen 19-9 nonproduction underpins worse pathologic response to neoadjuvant therapy in pancreatic cancer.

Mary P Martos, Erin M Dickey, Kawther Abdilleh

|Jun 30, 2025
Recurrence After Gallbladder Cancer Resection: Prognostic Impact of CA19-9 and CEA Levels at Baseline and During Surveillance.

Diamantis I Tsilimigras, Odysseas P Chatzipanagiotou, Andrea Ruzzenente

|Oct 14, 2024
Incidence and Prognostic Implications of Lymphovascular Invasion in Node-Negative Pancreatic Neuroendocrine Tumors: Results From the US Neuroendocrine Study Group.

Kota Sahara, Diamantis I Tsilimigras, Yuki Homma

Pageof 6

Frequent Collaborators

9 joint publications

David A Kooby

9 joint publications

Timothy M Pawlik

5 joint publications

Mihir M Shah

4 joint publications

Kenneth Cardona